Obesity Management
Digital Education Hubs
The field of obesity management is quickly evolving. New drug therapies and bariatric surgery are effective, but a larger understanding of social determinants, genetics, and the psychology behind obesity are proving to be essential pieces of the puzzle. Dismantling the myth that obesity is a lack of willpower or a “calories in, calories out” conundrum is necessary to shift the conversation away from placing blame and toward effective management.
CME/CE Activities
News Digest
Care in (un)Common Settings with Dr. Keith C. Ferdinand
Cardiometabolic Health Congress (CMHC) sat down with Dr. Keith C. Ferdinand, the Gerald S. Berenson Endowed Chair in preventive cardiology at Tulane School of Medicine
The Buzz With Newer Weight Loss Treatments
Experts in both obesity medicine and dermatology have a lot to say about Ozempic, the latest glucose-control drug being used for weight loss. According to
Prevention and Treatment of Pediatric Obesity: Utilizing the Spectrum of Available Tools to Optimize Treatment
The roots of cardiometabolic disease begin in childhood, but many clinicians do not feel confident about screening, diagnosing, and treating these conditions early on. This
Research Shows Most Women Enter Pregnancy in Poor Cardiometabolic Health
Obstetricians call pregnancy a “stress test” for a woman’s body. The increased blood volume puts extra burden on a woman’s circulatory and cardiovascular systems, and
A New Era of Obesity Treatment
A combination GIP and GLP-1 receptor could be the next groundbreaking treatment option for people with overweight or obesity, researchers reported. The first-of-its-kind class of
Bariatric surgery improves diabetes remission, reduces cardiometabolic risk
The following blog has been republished with permission from our partners at Healio. You can read the original article here. Compared with conventional treatment, bariatric
article
Obesity
article
Cardiometabolic Disease
article
Cardiometabolic Disease
Expert Highlights and Perspectives
Conversation about Obesity in T2DM
The Foundations of Managing Obesity in T2DM
- Adherence, Not Diet, Predict Success in Weight Loss
- Landmark Studies on Lifestyle Intervention: Diabetes Prevention Program
- Landmark Studies on Lifestyle Intervention: Look-Ahead
- Landmark Studies on Lifestyle Intervention: PROPEL
- Landmark Studies on Lifestyle Intervention: Translation to Clinical Care
Emerging Treatment Options for Long-Term Obesity Management
The Spectrum of Comprehensive Methods for Long-Term Weight Loss in T2DM
- More Weight Loss Provides More Clinical Benefit
- Current/ Old Treatment Paradigm for Cardiometabolic Diseases
- Medications for Weight Loss & Overview of Efficacy of FDA-Approved Treatments for Obesity
- Basic Rules for Prescribing Weight Loss Medications
- The Role of Metabolic Surgery in The Spectrum of Weight-Loss Interventions
- Bariatric Surgery Criteria
- Overview of Metabolic Surgery Procedures
Practical Approaches for Managing Obesity
Perspectives & Discussions: NAFLD and NASH Screening, Diagnosis, and Emerging Treatments
Watch Drs. Eckel and Harrison discuss some additional perspectives on the screening, diagnosis and emerging treatment options for NASH. Recorded Dec.1, 2022.
Additional Expert Perspectives on Current Treatment Options for NASH
Watch CMHC faculty Dr. Barb discussing some practical pearls and the current treatment approaches for NASH. Recorded Dec.15, 2022.
Clinical Pearls for the Long-Term Management of Obesity : Expert Perspectives and Discussions
- Importance of recognizing and documenting obesity as a disease
- Common questions from patients and providers about obesity treatment
- Individualization of obesity treatment
- Tips to improve reimbursement and insurance coverage for obesity management
- The paradigm shifts in obesity management
CMHC Annual 2021 Obesity Management Panel
CMHC Chair Robert Eckel and faculty Holly Wyatt, MD and Michelle Look, MD recap the obesity session topics discussed at the 16th Annual CMHC, including the importance of assessing and addressing pre-obesity, patient motivation advice, and considerations for long-term weight maintenance and obesity management.
CMHC Annual 2021 Rare Obesity Disorders Panel
CMHC Chair Robert Eckel, MD, recaps the session on rare obesity disorders discussed at the 16th Annual CMHC with session presenters Joan Han, MD, and Clair Francomano, MD. The session discussed monogenic disorders of obesity, including leptin pathway defects and Alström syndrome, as well as practical pearls for screening, diagnosis, and treatment.
Resources
NAFLD and/or NASH
NAFLD = non-alcoholic fatty liver disease; NASH = non-alcoholic steatohepatitis